Dixestivo
Servizo
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Canarias (110)
2024
-
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810
-
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759
-
Colonoscopy Satisfaction and Safety Questionnaire based on patient experience (CSSQP): A valuable quality tool for all colonoscopies
Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 1-13
-
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 2062-2074.e11
-
Development and validation of a faecal immunochemical test-based model in the work-up of patients with iron deficiency anaemia
Frontiers in Medicine, Vol. 11
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.
American Journal of Gastroenterology
-
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 4, pp. 578-588
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615
-
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612
-
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Digestive and Liver Disease
-
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study
Digestive and Liver Disease
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597
2023
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
Frontiers in Medicine
-
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
United European Gastroenterology Journal, Vol. 11, Núm. 7, pp. 692-699